Participating in a clinical trial is the first step to fighting cancer, not the last.
Talk to your physician about participating in a cancer clinical trial
or ASKSARAH (toll free) at
Clinical Trials »
Clinical trials are studies that evaluate the effectiveness of new drugs or treatment strategies. The development of more effective cancer treatments requires that new and innovative therapies be evaluated with cancer patients. Each clinical trial is designed to find new or better ways to treat cancer patients. In oncology, clinical trials are especially important because, in the absence of high cure rates, nearly all therapeutic approaches are developmental in nature. Our goal is to provide patients with all forms of investigational and approved therapies without the need to travel to other parts of the country.
Sarah Cannon Research Institute (SCRI), an industry leader in clinical trials, is dedicated to advancing solutions for patient care through clinical research. It is the largest community-based program in the nation, conducting clinical trials in ten therapeutic areas through its affiliation with a powerful network of hundreds of physicians. Additionally, it offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites across the country.
- Our work—SCRI is a strategic research organization that sponsors oncology clinical trials through its affiliation with clinical oncology practices throughout the country. This work makes it possible for thousands of cancer patients to participate in research studies close to home
- Our services to physician investigators and industry—SCRI provides research support services to oncologists, hematologists and drug development sponsors across the country
That’s why it’s so important to know your options. As a leader in cancer research, Sarah Cannon Research Institute and Tennessee Oncology are on a journey to discover new medication and device treatments for cancer. Participating in a clinical trial allows you to access to the most cutting-edge treatments available and ultimately may lead to developing new standards of care that are safer and more effective. The first step is yours. We’ll be with you the rest of the way.